Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
- PMID: 1676893
- DOI: 10.1016/0896-6273(91)90079-f
Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity
Abstract
Exposure of rat retinal cultures to HIV-1 coat protein gp120 for several minutes increases [Ca2+]i in approximately half of the ganglion cells; this effect is associated with delayed-onset neuronal injury, similar to that previously reported in NMDA receptor-mediated neurotoxicity. Here we show that NMDA antagonists can prevent both the rise in [Ca2+]i and subsequent neuronal damage engendered by 20 pM gp120. However, whole-cell patch-clamp recordings demonstrate that gp120 does not directly evoke an NMDA-like response or enhance glutamate/NMDA-activated currents. Moreover, complete protection from gp120-induced [Ca2+]i increases and neurotoxicity is afforded by incubation with glutamate-pyruvate transaminase, which breaks down endogenous glutamate as verified by HPLC. Since, under standard conditions in these cultures, neither glutamate nor a low picomolar concentration of gp120 is deleterious on its own, our results suggest that their neurotoxicity is synergistic.
Similar articles
-
Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture.Brain Res. 1991 Jun 14;551(1-2):297-302. doi: 10.1016/0006-8993(91)90944-q. Brain Res. 1991. PMID: 1680525
-
HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons.Eur J Neurosci. 1995 Nov 1;7(11):2285-93. doi: 10.1111/j.1460-9568.1995.tb00649.x. Eur J Neurosci. 1995. PMID: 8563977
-
Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA.J Neurochem. 1994 Sep;63(3):879-85. doi: 10.1046/j.1471-4159.1994.63030879.x. J Neurochem. 1994. PMID: 7914224
-
Molecular basis of glutamate toxicity in retinal ganglion cells.Vision Res. 1997 Dec;37(24):3483-93. doi: 10.1016/S0042-6989(97)00047-3. Vision Res. 1997. PMID: 9425525 Review.
-
HIV-related neurotoxicity.Brain Pathol. 1991 Apr;1(3):193-9. doi: 10.1111/j.1750-3639.1991.tb00659.x. Brain Pathol. 1991. PMID: 1669708 Review.
Cited by
-
Direct interaction of HIV gp120 with neuronal CXCR4 and CCR5 receptors induces cofilin-actin rod pathology via a cellular prion protein- and NOX-dependent mechanism.PLoS One. 2021 Mar 11;16(3):e0248309. doi: 10.1371/journal.pone.0248309. eCollection 2021. PLoS One. 2021. PMID: 33705493 Free PMC article.
-
Metabolic markers of neuronal injury correlate with SIV CNS disease severity and inoculum in the macaque model of neuroAIDS.Magn Reson Med. 2008 Mar;59(3):475-84. doi: 10.1002/mrm.21556. Magn Reson Med. 2008. PMID: 18306400 Free PMC article.
-
Opiate drug use and the pathophysiology of neuroAIDS.Curr HIV Res. 2012 Jul;10(5):435-52. doi: 10.2174/157016212802138779. Curr HIV Res. 2012. PMID: 22591368 Free PMC article. Review.
-
Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.Neurotox Res. 2007 Oct;12(3):181-204. doi: 10.1007/BF03033915. Neurotox Res. 2007. PMID: 17967742 Review.
-
Methamphetamine abuse, HIV infection, and neurotoxicity.Int J Physiol Pathophysiol Pharmacol. 2009 Sep 25;1(2):162-179. Int J Physiol Pathophysiol Pharmacol. 2009. PMID: 20411028 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous